Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
Temozolomide and thalidomide in the treatment of advanced melanoma, a phase II study
Okeke, I. R., Laber, D. A., Bev, T., McMasters, K. M., Miller, D. M.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Loading…
Clinical Trial: CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Published in US Fed News Service, Including US State News
(07.01.2021)
Get full text
Newsletter
Loading…
Loading…
Loading…
CI-980 in Advanced Melanoma and Hormone Refractory Prostate Cancer
Ryan, Christopher W., Shulman, Keith L., Richards, Jon M., Kugler, John W., Sosman, Jeffrey A., Ansari, Rafat H., Vokes, Everett E., Vogelzang, Nicholas J.
Published in Investigational new drugs (01.05.2000)
Published in Investigational new drugs (01.05.2000)
Get full text
Journal Article
Loading…
Combination Immunotherapy of Pembrolizumab with the Galectin-3 Inhibitor GR-MD-02 Shows Promising Early Results in Treatment of Advanced Melanoma from a Phase 1b Clinical Trial: The objective response rate in advanced melanoma was 62.5% (five of eight subjects)
Published in NASDAQ OMX's News Release Distribution Channel
(13.11.2017)
Get full text
Newsletter
Loading…
Loading…
Loading…
Biothera Pharmaceuticals Initiates Patient Dosing in Phase 2 Trial Investigating Imprime PGG and Merck's KEYTRUDA® (pembrolizumab): Study to combine therapies in patients with either advanced melanoma or metastatic triple negative breast cancer (TNBC)
Published in NASDAQ OMX's News Release Distribution Channel
(23.02.2017)
Get full text
Newsletter
Loading…
Bristol-Myers Squibb unveils early stopping of Phase III trial of nivolumab vs dacarbazine in advanced melanoma
Published in M2 Pharma
(25.06.2014)
Get full text
Newsletter
Loading…
Early Watch: Genta Announces a New Controlled Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
Published in M2 Presswire
(18.04.2007)
Get full text
Newsletter
Loading…
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy
Weiss, Sarah A., Sznol, Mario, Shaheen, Montaser, Berciano-Guerrero, Miguel-Ángel, Couselo, Eva Muñoz, Rodríguez-Abreu, Delvys, Boni, Valentina, Schuchter, Lynn M., Gonzalez-Cao, Maria, Arance, Ana, Wei, Wei, Ganti, Apar Kishor, Hauke, Ralph J., Berrocal, Alfonso, Iannotti, Nicholas O., Hsu, Frank J., Kluger, Harriet M.
Published in Clinical cancer research (05.01.2024)
Published in Clinical cancer research (05.01.2024)
Get full text
Journal Article
Loading…
Accounting for Cured Patients in Cost-Effectiveness Analysis
Othus, Megan, Bansal, Aasthaa, Koepl, Lisel, Wagner, Samuel, Ramsey, Scott
Published in Value in health (01.04.2017)
Published in Value in health (01.04.2017)
Get full text
Journal Article
Loading…
Enhancing systematic literature reviews with generative artificial intelligence: development, applications, and performance evaluation
Li, Ying, Datta, Surabhi, Rastegar-Mojarad, Majid, Lee, Kyeryoung, Paek, Hunki, Glasgow, Julie, Liston, Chris, He, Long, Wang, Xiaoyan, Xu, Yingxin
Published in Journal of the American Medical Informatics Association : JAMIA (01.04.2025)
Published in Journal of the American Medical Informatics Association : JAMIA (01.04.2025)
Get full text
Journal Article
Loading…
CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
Farwell, Michael D, Gamache, Raymond F, Babazada, Hasan, Hellmann, Matthew D, Harding, James J, Korn, Ron, Mascioni, Alessandro, Le, William, Wilson, Ian, Gordon, Michael S, Wu, Anna M, Ulaner, Gary A, Wolchok, Jedd D, Postow, Michael A, Pandit-Taskar, Neeta
Published in The Journal of nuclear medicine (1978) (01.05.2022)
Published in The Journal of nuclear medicine (1978) (01.05.2022)
Get full text
Journal Article
Loading…
Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance
Turner, David C., Kondic, Anna G., Anderson, Keaven M., Robinson, Andrew G., Garon, Edward B., Riess, Jonathan Wesley, Jain, Lokesh, Mayawala, Kapil, Kang, Jiannan, Ebbinghaus, Scot W., Sinha, Vikram, de Alwis, Dinesh P., Stone, Julie A.
Published in Clinical cancer research (01.12.2018)
Published in Clinical cancer research (01.12.2018)
Get full text
Journal Article